Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Theratechnologies Inc (NQ: THTX ) 1.260 -0.050 (-3.82%) Streaming Delayed Price Updated: 3:45 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Theratechnologies Inc < Previous 1 2 3 4 5 6 Next > Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance February 21, 2024 From Theratechnologies Via GlobeNewswire Earnings Scheduled For February 21, 2024 February 21, 2024 Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million. Via Benzinga Theratechnologies Earnings Preview February 20, 2024 Via Benzinga Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of Action February 20, 2024 From Theratechnologies Via GlobeNewswire Theratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer February 15, 2024 From Theratechnologies Via GlobeNewswire Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update February 06, 2024 From Theratechnologies Via GlobeNewswire Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLA January 24, 2024 From Theratechnologies Via GlobeNewswire Theratechnologies Receives Update from FDA on Tesamorelin F8 Supplemental Biologic License Application January 23, 2024 From Theratechnologies Via GlobeNewswire Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDA January 02, 2024 From Theratechnologies Via GlobeNewswire Theratechnologies Announces FDA Approval of Trogarzo® 90-Second Intravenous (IV) Push Loading Dose December 13, 2023 From Theratechnologies Via GlobeNewswire Theratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation Award November 24, 2023 Honor awarded last night recognizes Theratechnologies and Prof. Borhane Annabi for advancing preclinical development of sudocetaxel zendusortide for treatment of triple-negative breast cancer From Theratechnologies Via GlobeNewswire Theratechnologies Announces Closing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement October 31, 2023 From Theratechnologies Via GlobeNewswire Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session November 02, 2023 Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders. Via Benzinga Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session October 26, 2023 Gainers Via Benzinga PLTR Stock Alert: Study Ranks Palantir as Top AI Vendor October 26, 2023 Palantir Technologies stock is in the news as PLTR investors react of the company being named the top AI vendor for 2023. Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence CHPT Stock: ChargePoint Unveils New Software Solutions for Fleet Management October 26, 2023 ChargePoint stock is on the move Thursday as investors in CHPT react to the release of a new suite of tools for fleet owners. Via InvestorPlace Why Is Theratechnologies (THTX) Stock Down 22% Today? October 26, 2023 Theratechnologies stock is falling hard on Thursday after the company priced a public offering and private placement for THTX shares. Via InvestorPlace Why Endeavor Group Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket October 26, 2023 Gainers Appreciate Holdings, Inc. (NASDAQ: SFR) shares surged 103.8% to $0.2460 in pre-market trading after falling around 19% on Wednesday. Appreciate Holdings received a notice from Nasdaq regarding... Via Benzinga Theratechnologies Announces Pricing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement October 26, 2023 From Theratechnologies Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday October 26, 2023 It's time to start off Thursday with a breakdown of the biggest pre-market stock movers investors will want to watch this morning. Via InvestorPlace Theratechnologies Announces Proposed Public Offering of Common Shares and Concurrent Private Placement October 25, 2023 From Theratechnologies Via GlobeNewswire Theratechnologies Announces Operational Update October 24, 2023 From Theratechnologies Via GlobeNewswire Theratechnologies’ Ibalizumab Demonstrates Cost-Effectiveness as an Addition to Routine Clinical Care in Heavily Treatment-Experienced People with HIV October 19, 2023 From Theratechnologies Via GlobeNewswire Theratechnologies Announces Finalization of Amendments to Some of the Terms and Conditions of its Credit Agreement with Marathon October 16, 2023 From Theratechnologies Via GlobeNewswire Theratechnologies Presents Data at ID Week Showing Tesamorelin Reduces Visceral Adipose Tissue (VAT) and Liver Fat in People with HIV on Integrase Inhibitors (INSTIs) October 13, 2023 From Theratechnologies Via GlobeNewswire Theratechnologies Announces Results from Trogarzo® (Ibalizumab-uiyk) Intramuscular Administration Study October 13, 2023 From Theratechnologies Via GlobeNewswire Theratechnologies Announces Dosing of First Patient in Updated Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer October 12, 2023 From Theratechnologies Via GlobeNewswire Theratechnologies Receives January 2024 PDUFA Goal Date for Tesamorelin F8 Formulation sBLA October 04, 2023 From Theratechnologies Via GlobeNewswire Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates September 26, 2023 From Theratechnologies Via GlobeNewswire Earnings Scheduled For September 26, 2023 September 26, 2023 Companies Reporting Before The Bell • Ferguson (NYSE:FERG) is estimated to report quarterly earnings at $2.46 per share on revenue of $7.60 billion. Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
